GHR and acromegaly: No patients who underwent endoscopic transsphenoidal surgery in the acromegaly cohort were taking somatostatin analogs, GH receptor antagonists or dopamine agonists at or around the time of their surgery and no patients received radiation therapy prior to surgery.